| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/13/2002 | US20020071844 Acquired Immunodeficiency Syndrome in the human, Equine Infectious Anemia in the horse, and other viral diseases of man and animal, using at least an antiserum of equine origin. |
| 06/13/2002 | US20020071841 Recombinant toxin and monoclonal antibody which specifically binds to glial-derived or meningioma-derived tumor cells; screening for malignant gliomas and meningiomas; treating glioblastoma multiforme and astrocytomas. |
| 06/13/2002 | US20020071840 Method of therapeutic administration of anti-CD40L compounds |
| 06/13/2002 | US20020071839 Downmodulating the immune response to an intestinal allograft in a subject comprising administering an antibody that binds to B7-1 and an antibody that binds to B7-2. |
| 06/13/2002 | US20020071830 Expression vector is used to express a polypeptide comprising the core protein of a human polymorphic epithelial mucin, which core protein is specifically bound by monoclonal antibody, SM3. |
| 06/13/2002 | US20020071826 Targeted delivery system comprising at least one component-specific immunostimulating molecule bound to a platform. |
| 06/13/2002 | US20020071807 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 06/13/2002 | DE10060686A1 New anti-idiotypic antibody against antibodies of rheumatic immune complexes, useful for treatment and diagnosis of rheumatic autoimmune diseases |
| 06/13/2002 | DE10051983A1 Medicaments useful e.g. for preventing thrombosis, inhibiting transplant rejection or treating chronic inflammatory reactions comprises agents inhibiting binding of oxidized proteins to CD36, |
| 06/13/2002 | CA2716959A1 Glp-1 fusion proteins |
| 06/13/2002 | CA2436732A1 Protein modification and maintenance molecules |
| 06/13/2002 | CA2436671A1 Rationally designed antibodies |
| 06/13/2002 | CA2431861A1 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 06/13/2002 | CA2431203A1 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | CA2431202A1 Human sprouty-4 polypeptide |
| 06/13/2002 | CA2430993A1 G-protein coupled receptors |
| 06/13/2002 | CA2430716A1 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | CA2430713A1 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use |
| 06/13/2002 | CA2430624A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 06/13/2002 | CA2430558A1 Proteins and nucleic acids encoding same |
| 06/13/2002 | CA2430536A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | CA2430524A1 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof |
| 06/13/2002 | CA2430379A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | CA2430191A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | CA2429959A1 Adipocyte complement related protein zacrp3x2 |
| 06/13/2002 | CA2429641A1 Kinases and phosphatases |
| 06/13/2002 | CA2428390A1 Enzymes |
| 06/13/2002 | CA2428382A1 Intestinal proteins |
| 06/13/2002 | CA2428208A1 Lipid-associated molecules |
| 06/13/2002 | CA2428097A1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | CA2427820A1 Method of producing biospecific molecules by protein trans-splicing |
| 06/13/2002 | CA2427615A1 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 06/13/2002 | CA2425396A1 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/13/2002 | CA2364983A1 Nucleic acid molecules and polypeptides for catabolism of abscisic acid |
| 06/12/2002 | EP1213587A1 Particles having gelatin coatings of and processes for making same |
| 06/12/2002 | EP1213586A1 Method of fractional measurement of soluble cd14 protein |
| 06/12/2002 | EP1213302A1 Specific antibody directed to active but not inactive hepatocyte growth factor activator (HGFA) |
| 06/12/2002 | EP1213301A2 Anti-abnormal type prion monoclonal antibody, process for producing the same, and immunoassay using the same |
| 06/12/2002 | EP1213300A1 Novel human androgen receptor variants |
| 06/12/2002 | EP1213028A1 Hm1.24 antigen expression potentiators |
| 06/12/2002 | EP1212436A2 Protein phosphatase and kinase proteins |
| 06/12/2002 | EP1212433A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 06/12/2002 | EP1212431A2 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 06/12/2002 | EP1212427A2 Basb128 polypeptide and polynucleotide fron moraxella catarrhalis |
| 06/12/2002 | EP1212426A1 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
| 06/12/2002 | EP1212422A2 Human ctla-4 antibodies and their uses |
| 06/12/2002 | EP1212421A1 Gas1 polypeptides |
| 06/12/2002 | EP1212417A2 Interleukin-1-receptor associated kinase-3 (irak3) |
| 06/12/2002 | EP1212415A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212412A2 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
| 06/12/2002 | EP1212410A2 Dna encoding the human serine protease eos |
| 06/12/2002 | EP1212407A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212366A2 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 06/12/2002 | EP1212363A2 Il-16 antagonists |
| 06/12/2002 | EP1212362A2 Card proteins involved in cell death regulation |
| 06/12/2002 | EP1212361A1 Preparation of highly pure toxin fragments |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212343A1 52 human secreted proteins |
| 06/12/2002 | EP1212342A2 18 human secreted proteins |
| 06/12/2002 | EP1212340A1 29 human cancer associated proteins |
| 06/12/2002 | EP1212100A2 Delivery system for antidandruff agent |
| 06/12/2002 | EP1212088A1 Method for treatment of symptoms of central nervous system disorders |
| 06/12/2002 | EP1212087A1 Methods and compositions utilizing rad51 |
| 06/12/2002 | EP1212082A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 06/12/2002 | EP1212043A2 Composition to be administered through mucous membrane |
| 06/12/2002 | EP1084227A4 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| 06/12/2002 | EP0873362B1 PROCESS FOR ISOLATING IgG AND IgA |
| 06/12/2002 | EP0822941B1 Monoclonal antibodies against hiv-1 and vaccines made thereof |
| 06/12/2002 | EP0749325B1 Bispecific molecules having clinical utilities |
| 06/12/2002 | EP0574395B1 Cytokine immunoconjugates |
| 06/11/2002 | US6403957 Nucleic acid reading and analysis system |
| 06/11/2002 | US6403771 Loading onto binding medium relatively long lived radioisotope, decay sequence yielding daughter isotopes that emit predominantly alpha-and/or beta-particles, eluting alpha-particle emitting isotope, coupling to targeting moiety |
| 06/11/2002 | US6403770 Antibodies to neutrokine-alpha |
| 06/11/2002 | US6403769 Fusion protein having nonantibody portion comprised of effector domain from growth factor or growth factor receptor joined to aminoterminal end of immunoglobulin g-derived sequence which lacks ch1 domain |
| 06/11/2002 | US6403559 C-kit ligand-based method for expanding peripheral blood cell levels |
| 06/11/2002 | US6403557 Fibroblast growth factor-13 |
| 06/11/2002 | US6403552 Ob receptor and methods for the diagnosis and treatment of body weight disorders |
| 06/11/2002 | US6403374 Long wavelength engineered fluorescent proteins |
| 06/11/2002 | US6403371 Cassettes for the expression of storable proteins in plants |
| 06/11/2002 | US6403360 Isolated nucleic acids |
| 06/11/2002 | US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering |
| 06/11/2002 | US6403327 Diagnostic method using expression of MN/CA9 protein in ASCUS Pap smears |
| 06/11/2002 | US6403326 Methods of using antibodies against human luteinizing hormone-related determinants to detect and enrich human malignant cells |
| 06/11/2002 | US6403300 Monoclonal antibodies for detection of friend murine leukemia virus |
| 06/11/2002 | US6403102 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | US6403101 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | US6403097 Deletion in the glycoprotein ge-gene |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6403090 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
| 06/11/2002 | US6403089 Inhibitors of fgl2; bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, gastrointestinal diseases and fetal loss; monoclonal and polyclonal antibodies which bind to fgl2 and prevent fibrin |
| 06/11/2002 | US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease |
| 06/11/2002 | US6403082 Administering polynucleotide |
| 06/11/2002 | US6403077 Treatment regimes featuring an IL-10-containing chimeric polypeptide |
| 06/11/2002 | US6402913 Separation of plasma components |
| 06/11/2002 | CA2169629C Human erythropoietin receptor fragment and antibodies thereto |
| 06/11/2002 | CA2152266C Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/turyosinase peptide antigens |
| 06/11/2002 | CA2124218C Cytotoxic drug therapy |
| 06/11/2002 | CA2088478C Cloning and expression of a rhoptry associated protein of p. falciparum |
| 06/11/2002 | CA2082390C Dna encoding human 5-ht1d receptors and uses thereof |
| 06/11/2002 | CA2073186C Gene deleted in colorectal cancer in humans |